Literature DB >> 20655528

What is a normal thyroid-stimulating hormone (TSH) level? Effects of stricter TSH thresholds on pregnancy outcomes after in vitro fertilization.

Andrea Reh1, James Grifo, Ann Danoff.   

Abstract

Using a thyroid-stimulating hormone (TSH) cutoff of 2.5 mIU/L or 4.5 mIU/L, no differences in the rates of clinical pregnancy, delivery, or miscarriage were observed in this large, retrospective cohort study of first-cycle IVF patients from 2005 through 2008, after controlling for age. Although lowering the TSH threshold to 2.5 mIU/L would result in a nearly fivefold increase in the number of women being classified as hypothyroid, the lack of differences in maternal clinical outcomes must be considered in the current controversy regarding the relative merits of lowering the upper limit of normal of TSH. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655528     DOI: 10.1016/j.fertnstert.2010.06.041

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  40 in total

1.  Effect of autoimmune thyroid disease in older euthyroid infertile woman during the first 35 days of an IVF cycle.

Authors:  Andrea Reh; Sonal Chaudhry; Felicia Mendelsohn; Shelly Im; Linda Rolnitzky; Alana Amarosa; Mortimer Levitz; Suman Srinivasa; Lewis Krey; Alan S Berkeley; James A Grifo; Ann Danoff
Journal:  Fertil Steril       Date:  2010-11-03       Impact factor: 7.329

2.  2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction.

Authors:  Kris Poppe; Peter Bisschop; Laura Fugazzola; Gesthimani Minziori; David Unuane; Andrea Weghofer
Journal:  Eur Thyroid J       Date:  2021-01-21

3.  Thyroid-Stimulating Hormone Values in Pregnancy: Cutoff Controversy Continues?

Authors:  Suvarna Khadilkar
Journal:  J Obstet Gynaecol India       Date:  2019-09-13

4.  Association between TSH Level and Pregnancy Outcomes in Euthyroid Women Undergoing IVF/ICSI: A Retrospective Study and Meta-analysis.

Authors:  Lei Jin; Meng Wang; Jing Yue; Gui-Jin Zhu; Bo Zhang
Journal:  Curr Med Sci       Date:  2019-07-25

5.  Thyroid stimulating hormone levels rise after assisted reproductive technology.

Authors:  Shauna Reinblatt; Belen Herrero; José A Correa; Einat Shalom-Paz; Baris Ata; Amir Wiser; David Morris; Hananel Holzer
Journal:  J Assist Reprod Genet       Date:  2013-08-18       Impact factor: 3.412

6.  Subclinical elevations of thyroid-stimulating hormone and assisted reproductive technology outcomes.

Authors:  Konstantinos G Michalakis; Tolga B Mesen; Lynae M Brayboy; Bo Yu; Kevin S Richter; Michael Levy; Eric Widra; James H Segars
Journal:  Fertil Steril       Date:  2011-03-31       Impact factor: 7.329

7.  Investigating the optimal preconception TSH range for patients undergoing IVF when controlling for embryo quality.

Authors:  Katherine A Green; Marie D Werner; Jason M Franasiak; Caroline R Juneau; Kathleen H Hong; Richard T Scott
Journal:  J Assist Reprod Genet       Date:  2015-08-18       Impact factor: 3.412

8.  Subclinical Hypothyroidism and Thyroid Autoimmunity Are Not Associated With Fecundity, Pregnancy Loss, or Live Birth.

Authors:  Torie C Plowden; Enrique F Schisterman; Lindsey A Sjaarda; Shvetha M Zarek; Neil J Perkins; Robert Silver; Noya Galai; Alan H DeCherney; Sunni L Mumford
Journal:  J Clin Endocrinol Metab       Date:  2016-03-29       Impact factor: 5.958

9.  Do elevated TSH levels predict early pregnancy loss in ART patients?

Authors:  Julian A Gingold; Kelly Zafman; Jorge Rodriguez-Purata; Michael C Whitehouse; Joseph A Lee; Benjamin Sandler; Alan B Copperman
Journal:  Gynecol Endocrinol       Date:  2016-07-16       Impact factor: 2.260

10.  Fertility biomarkers to estimate metabolic risks in women with polycystic ovary syndrome.

Authors:  Laura Detti; Heather E Jeffries-Boyd; Lucy J Williams; Michael P Diamond; Rebecca A Uhlmann
Journal:  J Assist Reprod Genet       Date:  2015-11-05       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.